Omega-3 fish oil added to TB treatment
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You have a confirmed case of TB in your lungs (positive sputum or culture test)
- You do not have a known fish or fish oil allergy
- You do not take omega-3 or omega-6 supplements, or you can stop for the study
- If you have HIV, your CD4 count is above 100 and viral load is well controlled (if on treatment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.